Morgan Stanley initiates coverage of Amrize Ltd with Overweight rating and $62 price target.

From Financial Modeling Prep: 2025-06-24 07:16:00

Morgan Stanley initiates coverage of Amrize Ltd (OTCBB: AMRZ) with Overweight rating and $62.00 price target, citing aggressive acquisition strategy and strong free cash flow outlook. Revenue and EBITDA have grown at 13% and 16% CAGR since 2021, driven by 17 acquisitions. Projected $7.5 billion free cash flow (2025-2028) and low Net Debt/EBITDA offer financial flexibility.

Amrize is the 5th largest U.S. aggregates player with a 3% residential roofing market share. Morgan Stanley’s base case assumes 2% annual bolt-on growth. Upside risk exists if larger platform acquisitions accelerate scale. Monitoring leverage and profitability trends using Financial Growth Statement Analysis and Ratios TTM Statement Analysis APIs is recommended.

With strong free cash generation and sub-1x leverage, Amrize is well-positioned for acquisitions and EBITDA growth. Projected 15% CAGR (2025-2030) under a 1.5x leverage scenario outpaces peers. Investors can track growth metrics and capital structure in real time with FMP APIs, aligning with Morgan Stanley’s bullish outlook.



Read more at Financial Modeling Prep:: Amrize Ltd (AMRZ) Gets Overweight Nod and $62 Pric…